Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal β-oxidation defects

Journal of Clinical Investigation

Volumn 97, Issue 3, 1996, Pages 681-688

  Paton, Barbara C ^a   Sharp, Peter C ^a   Crane, Denis I ^b   Poulos, Alf ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

bile acids and salts; fatty acids; phytanic acid; prenatal diagnosis; Zellweger syndrome

Indexed keywords

ACYL COENZYME A OXIDASE; PHYTANIC ACID; VERY LONG CHAIN FATTY ACID;

ARTICLE; FATTY ACID OXIDATION; HUMAN; HUMAN CELL; PATHOGENESIS; PEROXISOME; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; ZELLWEGER SYNDROME;

EID: 0030058582     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118465     Document Type: Article

References (54)

1. Roscher, A A., S. Hoefler, G. Hoefler, E. Paschke, F. Paltauf, A. Moser, and H. Moser. 1989. Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis A complementation study involving cell lines from 19 patients. Pediatr. Res. 26:67-72.
2. Shimozawa, N., Y. Suzuki, T. Orii, A. Moser, H.W. Moser, and R.J.A. Wanders. 1993 Standardization of complementation grouping of peroxisome-deficient disorders and the second Zellweger patient with peroxisomal assembly factor-1 (PAF-1) defect. Am. J. Hum Genet 52:843-844.
3. Poulos, A., J. Christodoulou, C.W. Chow, J. Goldblatt, B.C. Paton, T. Orii, Y. Suzuki, and N Shimozawa 1995. Peroxisomal assembly defects, clinical, pathological, and biochemical findings in two patients belonging to a newly identified complementation group. J. Pediatrics 127:596-599
4. Motley, A., E. Hettema, B. Distel, H. Tabak. 1994. Differential protein import deficiencies in human peroxisome assembly disorders. J Cell Biol. 125: 755-767.
5. Dodt, G., N. Braverman, C Wong, A. Moser, H.W. Moser, P. Watkins, D. Valle, and S J. Gould. 1995. Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. Nat. Genet. 9:115-125.
6. Brul, S. A. Westerveld, A Strijland, R.J.A Wanders, A.W. Schram, H.S.A. Heymans, R.B.H. Schutgens, H. van den Bosch, and J.M. Tager. 1988 Genetic heterogeneity in the cerebrohepatorenal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions. A study using complementation analysis J. Clin Invest 81:1710-1715
7. Singh, A.K., N. Kulvatunyou, I Singh, and W.S. Stanley. 1989. In situ genetic complementation analysis of cells with generalized peroxisomal dysfunction. Hum Hered 39:298-301.
8. Yajima, S , Y. Suzuki, N. Shimozawa, S Yamaguchi, T. Orii, Y. Fujiki, T. Osumi, T Hashimoto, and H.W. Moser. 1992 Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells. Hum Genet 88:491-499.
9. Poll-The, B.T., O.H. Skjeldal, O. Stokke, A. Poulos, F. Dernaugre, J -M Saudubray 1989 Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders. Hum. Genet. 81:175-181.
10. McGuinness, M.C., A.B Moser, H.W. Moser, and P.A. Watkins. 1990. Peroxisomal disorders: complementation analysis using beta-oxidation of very long chain fatty acids. Biochem. Biophys. Res. Commun. 172:364-369.
11. Hoefler, G., E. Paschke, S. Hoefler, A.B. Moser, and H.W. Moser. 1991. Photosensitized killing of cultured fibroblasts from patients with peroxisomal disorders due to pyrene fatty acid-mediated ultraviolet damage. J. Clin. Invest. 88 1873-1879
12. Schram, A.W., S. Goldfischer, C.W.T. van Roermund, E.M. Brouwer-Kelder, J. Collins, T Hashimoto, H.S.A. Heymans, H. van den Bosch, R.B.H. Schutgens, J M. Tager, and R.J A. Wanders. 1987. Human peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency. Proc. Natl. Acad Sci. USA. 84:2494-2496.
13. Poll-The, B.T., F Roels, H. Ogier, J. Scotto, J. Vamecq, R.B.H. Schutgens, R.J.A. Wanders, C.W.T. van Roermund, M.J.A. van Wijland, A.W. Schram, J.M. Tager, and J.-M. Saudubray. 1988 A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy) Am. J Hum. Genet. 42:422-434.
14. Watkins, P.A., W.W. Chen, C.J. Harris, G. Hoefler, S. Hoefler, D.C. Blake, A. Balfe, R.I. Kelley, AB. Moser, M.E Beard, and H.W. Moser. 1989. Peroxisomal bifunctional enzyme deficiency. J. Clin. Invest. 83:771-777.
15. Clayton, P.T., B.D. Lake, M. Hjelm, J.B.P. Stephenson, G.T N Besley, R.J.A. Wanders, A.W. Schram, J.M Tager, R.B.H. Schutgens, and A.M. Lawson 1988. Bile acid analyses in "Pseudo-Zellweger" syndrome; clues to the defect in peroxisomal β-oxidation. J. Inherited Metab. Dis. 11 (Suppl 2):165-168.
16. Naidu, S., G. Hoefler, P.A. Watkins, W.W Chen, A.B. Moser, S. Hoefler, N.E. Rance, J.M. Powers, M. Beard, W.R. Green et al. 1988. Neonatal seizures and retardation in a girl with biochemical features of X-linked adrenoleukodystrophy. A possible new peroxisomal disease entity. Neurology. 38:1100-1107.
17. Barth, P.G., R.J.A. Wanders, R B.H. Schutgens, E.M Bleeker-Wagemakers, and D. van Heemstra. 1990. Peroxisomal β-oxidation defect with detectable peroxisomes, a case with neonatal onset and progressive course. Eur. J. Pediatr. 149:722-726.
18. Nakada, Y , N. Hyakuna, Y. Suzuki, N. Shimozawa, E. Takaesu, R. Ikema, and K. Hirayama 1993. A case of pseudo-Zellweger syndrome with a possible bifunctional enzyme deficiency but detectable enzyme protein. Comparison of two cases of Zellweger syndrome. Brain Dev. 15:453-456.
19. Santer, R., A. Claviez, H.D. Oldigs, J. Schaub, R.B.H. Schutgens, and R.J.A. Wanders. 1993 Isolated defect of peroxisomal β-oxidation in a 16-year-old patient. Eur. J. Pediatr 152:339-342.
20. Wanders, R.J.A., C.W.T. van Roermund, S. Brul, R.B.H. Schutgens, and J. M. Tager. 1992. Bifunctional enzyme deficiency: identification of a new type of peroxisomal disorder in a patient with an impairment in peroxisomal β-oxidation of unknown aetiology by means of complementation analysis J. Inheritable Metab. Dis. 15:385-388
21. McGuinness, M C , A.B Moser, B T Poll-The, and P.A. Watkins. 1993 Complementation analysis of patients with intact peroxisomes and impaired peroxisomal β-oxidation. Biochem. Med. Metab. Biol 49:228-242.
22. Suzuki, Y , N. Shimozawa, S. Yajima, S. Tomatsu, N. Kondo, Y. Nakada, S Akaboshi, M. Iai, Y. Tanabe, T. Hashimoto, R.J.A. Wanders et al. 1994. Novel subtype of peroxisomal acyl-CoA oxidase deficiency and bifunctional enzyme deficiency with detectable enzyme protein: Identification by means of complementation analysis. Am. J. Hum Genet. 54:36-43.
23. Poulos, A., P. Sharp, A J. Fellenberg, and D.W. Johnson. 1988. Accumulation of pristanic acid (2,6,10,14 tetramethylpentadecanoic acid) in the plasma of patients with generalized peroxisomal dysfunction. Eur. J. Pediatr 147:143-147
24. ten Brink, H.J., R.J.A Wanders, F. Stellaard, R.B.H. Schutgens, and C Jakobs. 1991. Pristanic acid and phytanic acid in plasma from patients with a single peroxisomal enzyme deficiency. J. Inheritable Metab. Dis 14 345-348.
25. ten Brink, H J , B.T. Poll-The, J.M. Saudubray, R.J.A. Wanders, and C. Jakobs 1991. Pristanic acid does not accumulate in peroxisomal acyl-CoA oxidase deficiency: evidence for a distinct peroxisomal pristanoyl CoA oxidase. J. Inheritable Metab. Dis. 14:681-684.
26. Vanhove, G.F., P P. Van Veldhoven, M. Fransen, S. Denis, H.J. Eyssen, R.J.A. Wanders, and G.P Mannaerts. 1993. The CoA esters of 2-methyl-branched chain fatty acids and of the bile acid intermediates di- and trihydroxycoprostanic acids are oxidized by one single peroxisomal branched chain acyl-CoA oxidase in human liver and kidney J. Biol Chem. 268:10335-10344
27. Clayton, P.T., E. Patel, A.M. Lawson, R.A Carruthers, and J. Collins. 1990. Bile acid profiles in peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency J. Clin. Invest. 85:1267-1273.
28. Poulos, A., R. Gibson, P. Sharp, K Beckman, P. Grattan-Smith. 1994. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil. Ann Neurol. 36:741-746.
29. Schutgens, R.B.H., G.J. Romeyn, R.J.A Wanders, H. van den Bosch, G. Schrakamp, and H.S.A. Heymans. 1984. Deficiency of acyl-CoA:dihydroxy-acetone phosphate acyltransferase in patients with Zellweger (cerebro-hepatorenal) syndrome. Biochem. Biophys Res. Commun. 120:179-184.
30. Singh, H., K. Beckman, and A. Poulos. 1993. Exclusive localization in peroxisomes of dihydroxyacetone phosphate acyltransferase and alkydihydroxyacetone phosphate synthase in rat liver. J. Lipid Res. 34:467-477.
31. Wanders, R.J.A., M. Kos, B. Roest, A.J. Meijer, G. Schrakamp, H.S.A. Heymans, W.H.H Tegelaers, H. van den Bosch, R.B.H. Schutgens, and J M. Tager. 1984. Activity of peroxisomal enzymes and intracellular distribution of catalase in Zellweger syndrome Biochem. Biophys Res Commun. 123:1054-1061
32. Aebi, H. 1984. Catalase in vitro. In Methods in Enzymology, Vol. 105. Oxygen Radicals in Biological Systems. L. Packer, editor. Academic Press. Orlando, FL. 121-126.
33. Singh, H. S. Usher, D Johnson, and A. Poulos. 1990 A comparative study of straight chain and branched chain fatty acid oxidation in skin fibroblasts from patients with peroxisomal disorders. J. Lipid Res. 31:217-225.
34. 14C]phytanic acid as substrate. Clin. Genet 20:247-253.
35. Nelson, P.V., and W.F. Carey 1985. A method for enrichment of hybrid somatic cells: complementation studies in certain lysosomal enzymopathies. J. Inheritable Metab. Dis. 8:95-99.
36. Brul, S., E.A.C. Wiemer, A. Westerveld, A. Strijland, R J.A. Wanders, A.W. Schram, H.S.A. Heymans, R B.H Schutgens, H. Van Den Bosch, and J.M. Tager. 1988. Kinetics of the assembly of peroxisomes after fusion of complementary cell lines from patients with the cerebro-hepato-renal (Zellweger) Syndrome and related disorders Biochem. Biophys. Res. Commun 152:1083-1089.
37. Stanczak, H , K Kremser, A.K. Singh, J. Ashcraft, W. Stanley, and I. Singh. 1992. Complementation in Zellweger syndrome: biochemical analysis of newly generated peroxisomes. Hum. Hered. 42:172-178.
38. Peterson, G.L. 1977. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem. 83:346-356
39. Tan, KK 1978. Assay of proteins by Lowry's method in samples containing 2-mercaptoethanol. Anal. Biochem. 86:327-331.
40. Chen, N., D.I. Crane, and C.J. Masters. 1988. Analysis of the major integral membrane proteins of peroxisomes from mouse liver. Biochim. Biophys. Acta. 945:135-144.
41. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl. Acad. Sci. USA. 76:4350-4354.
42. Dunn, S.D. 1986. Effects of the modification of transfer buffer composition and the renaturation of proteins in gels on the recognition of proteins on western blots by monoclonal antibodies. Anal. Biochem. 157:144-153.
43. Price, V.E., W. R. Sterling, V.A. Tarantola, R.W. Hartley, Jr., and M. Rechcigl, Jr. 1962. The kinetics of catalase synthesis and destruction in vivo. J. Biol. Chem 237:3468-3475.
44. Lazarow, P.B., and C de Duve. 1973. The synthesis and turnover of rat liver peroxisomes: V. Subcellular pathway of catalase synthesis. J. Cell Biol 59: 507-524.
45. Crane, D.I., N. Chen, and CJ. Masters. 1989. Evidence that the enoyl-CoA hydratase bifunctional protein of mouse liver peroxisomes is identical with the 70,000 dalton peroxisomal membrane protein. Biochem. Biophys. Res Commun 160:503-508.
46. ten Brink, H.J., F. Stellaard, C.M.M. van den Heuvel, R.M. Kok, D.S.M. Schor, R.J A Wanders, and C. Jakobs. 1992. Pristanic acid and phytanic acid in plasma from patients with peroxisomal disorders, stable isotope dilution analysis with electron capture negative ion mass fragmentography. J Lipid Res. 33:41-47.
47. Carey, W F., A. Poulos, P. Sharp, P.V. Nelson, E.F. Robertson, J L. Hughes, and A. Gill. 1994. Pitfalls in the prenatal diagnosis of peroxisomal β-oxidation defects by chorionic villus sampling. Prenatal Diagn. 14:813-819.
48. Wanders, R.J.A., R.B.H. Schutgens, P.G. Barth, J.M. Tager, and H. van den Bosch 1993. Postnatal diagnosis of peroxisomal disorders: A biochemical approach. Biochimie (Paris) 75:269-279.
49. Espeel, M., F. Roels, L Van Maldergem, D. De Craemer, G. Dacremont, R.J.A. Wanders, and T. Hashimoto. 1991. Peroxisomal localization of the immunoreactive β-oxidalion enzymes in a neonate with a β-oxidation defect Virchows Archiv. A Pathol Anat. 419:301-308.
50. 2-enoyl CoA isomerase activities J Biol Chem. 265:2446-2449.
51. Novikov, D.K., G.F. Vanhove, H. Carchon, S. Asselberghs, H.J. Eyssen, P.P Van Veldhoven, and G.P. Mannaerts 1994 Peroxisomal β-oxidation. Purification of four novel 3-hydroxyacyl-CoA dehydrogenases from rat liver peroxisomes J. Biol Chem. 269:27125-27135.
52. Martinez, M., I. Mougan, M. Roig, and A. Ballabriga. 1994. Blood polyunsaluraled fatty acids in patients with peroxisomal disorders. A multicenter study. Lipids. 29:273-280.
53. Hughes, J.L., D.I. Crane, E Robertson, and A. Poulos 1993. Morphometry of peroxisomes and immunolocalization of peroxisomal proteins in the liver of patients with generalized peroxisomal disorders. Virchows Archiv A Pathol. Anat. 423:459-468.
54. Roels, F , M. Pauwels, B.T. Poll-Thé, J. Scotto, H. Ogier, P. Aubourg, and J.-M. Saudubray. 1988 Hepatic peroxisomes in adrenoleukodystrophy and related syndromes: Cytochemical and morphometric data. Virchows Archiv. A Pathol. Anat. 413: 275-285.